UPDATE: Goldman Sachs Lowers PT on Rite Aid Corporation on Weak March Sales

In a report published Friday, Goldman Sachs analyst Matthew J. Fassler reiterated a Neutral rating on Rite Aid Corporation (NYSE: RAD ), but slightly lowered the price target from $1.85 to $1.75. In the report, Fassler noted, “RAD reported March sales including pharmacy volume that were a tad light, partially